Analysis of the gene expression of CD4+ T lymphocytes activated with potentised sulphur from patients with periodontal inflammation and a healthy control group
An in vitro - ex vivo study.
Project overview
Periodontitis is an inflammatory disease of the gums and periodontium that leads to tooth loss if left untreated. Every second adult suffers from a moderate form of periodontitis, every tenth adult suffers from a severe form. From an immunological point of view, certain leukocyte subpopulations are found at the site of the inflammatory reaction.
In our preliminary work on basic research projects with potentised substances in 2010 and 2015, activated CD4+ T lymphocytes and granulocytes from periodontitis blood donors have already been observed. In particular, a specific immunomodulatory effect of potentised sulphur on human cells can be assumed. Other experts in the field of basic research on homeopathy have also already taken up gene expression models. However, little is known about the gene expression of homeopathically stimulated immunomodulating human cells in a periodontitis donor group compared to a healthy control group.
Participants wanted!
If you would like to support our study, please contact us!
We are looking for 25 participants for each of two groups:
- Group 1 (patients): People with diagnosed, untreated periodontitis
- Group 2 (control group): Healthy volunteers without periodontitis and without gum inflammation
Requirements for participation
- Age: 18 - 80 years
- Periodontitis patients: Confirmed diagnosis, no treatment/therapy yet
- Control group: Healthy gums/no periodontitis findings
- Written consent
Excluded are persons who
- have taken pain or inflammation medication (e.g. ibuprofen, paracetamol) or antibiotics in the last 6 months.
- are taking medication for rheumatism (e.g. cortisone, immunosuppressants, TNF blockers).
- are pregnant or breastfeeding.
- have systemic diseases (e.g. diabetes).
- smoke.
- are receiving homeopathic treatment.
Procedure of the study
After giving informed consent, blood is taken once from the test subjects (15 ml, approximately one tablespoon). The CD4+ T lymphocytes are isolated from the blood in the laboratory. These cells are stimulated with sulphur D12 and their gene expression (activity of certain genes, especially inflammatory messengers) is then measured. All laboratory work is only carried out with the extracted cells; the test subjects themselves do not take part in any further tests. A short examination and blood collection in presence is required for participation. The appointments take place in Witten (Alfred-Herrhausen-Straße and Stockumer Straße) and last approx. 30 to 60 minutes.
Compensation
Each participant receives €40 for time spent and travelling expenses.
Further information
- Responsible: Chair of Medical Theory, Integrative and Anthroposophic Medicine
- Funding: Software AG - Foundation
- Cooperation partners:
Prof. Dr Thomas Dittmar, Chair and Institute of Immunology (Scientific Director)
Prof. Dr med. dent. Anton Friedmann, Chair of Periodontology (Dental Director)
Prof. Dr Thomas Ostermann, Chair of Research Methodology and Statistics in Psychology (Biometry and Statistics)
Discourse
With these in-vitro and ex-vivo experiments, we aim to open up an outlook and a perspective. Addressing the question of the mechanisms of action of potentised substances on human cells and the transferability of the results into clinical practice is in the spirit of translational research.
Project management
Dr rer. medic.
Christa Kunigunde Raak
Researcher
Faculty of Health (School of Medicine) | Chair of Medical Theory, Integrative and Anthroposophic Medicine
- +49 2330 62-3643
Orcid ID: 0000-0002-8056-6869
Gerhard-Kienle-Weg 4
58313 HerdeckeRoom number: Haus D, DG